HealthCor Management, L.P. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.

Quarter-by-quarter ownership
HealthCor Management, L.P. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2019$5,861,000
-76.1%
1,491,376
-9.5%
0.22%
-76.7%
Q2 2019$24,507,000
-29.4%
1,648,090
+17.9%
0.95%
-32.2%
Q1 2019$34,706,000
+222.1%
1,398,300
+133.0%
1.40%
+316.0%
Q4 2018$10,776,000
-83.7%
600,000
-38.4%
0.34%
-84.4%
Q4 2017$66,221,000
+24.1%
973,840
+50.4%
2.16%
+20.5%
Q3 2017$53,347,000
-4.5%
647,420
+8.6%
1.79%
-11.3%
Q2 2017$55,832,000
+192.3%
596,300
+98.8%
2.02%
+130.0%
Q1 2017$19,101,000
-31.2%
300,000
-52.0%
0.88%
-44.2%
Q4 2016$27,763,000
+10.0%
625,000
-10.7%
1.57%
+2.0%
Q3 2016$25,235,000
-30.6%
700,000
-73.6%
1.54%
-22.4%
Q2 2016$36,358,000
-5.3%
2,650,000
+32.5%
1.98%
-8.9%
Q1 2016$38,400,000
-28.1%
2,000,000
+31.1%
2.18%
-32.9%
Q4 2015$53,375,000
+62.2%
1,525,000
+221.1%
3.24%
+63.8%
Q1 2014$32,903,000
+453.9%
475,000
+381.9%
1.98%
+448.2%
Q4 2013$5,940,000
-61.8%
98,563
-61.5%
0.36%
-56.7%
Q3 2013$15,566,000
+85.9%
256,021
+104.8%
0.83%
+64.8%
Q2 2013$8,373,000125,0000.51%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders